BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32495394)

  • 1. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
    Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
    Wang Y; Xu J; Zhu X; Kuang H
    Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
    Zheng M; Xu L; Wei C; Guan W
    Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.
    Dai L; Zhang W; Wu X; Zhou S
    J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200c-3p Negatively Regulates ATP2A2 and Promotes the Progression of Papillary Thyroid Carcinoma.
    Feng YL; Ke T; Wang GL; Qi HY; Xiao Y
    Biochem Genet; 2022 Oct; 60(5):1676-1694. PubMed ID: 35079913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DNAJC3-AS1 promotes the biological functions of papillary thyroid carcinoma via regulating the microRNA-27a-3p/CCBE1 axis.
    Ni T; Li Y; Guo D; Tan L; Xiao Z; Shi Y
    Cell Biol Int; 2023 Mar; 47(3):539-547. PubMed ID: 36583660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.
    Li R; Wan T; Qu J; Yu Y; Zheng R
    Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4.
    Zhang C; Chang Q; Hu Y; Chang W; Guo X; Fu L; Tang G; Chen C
    Histol Histopathol; 2021 Nov; 36(11):1199-1207. PubMed ID: 34708859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis.
    Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D
    Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
    Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
    Wei T; Zhu X
    J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.
    You A; Fu L; Li Y; Li X; You B
    Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1.
    Li P; Pan X; Zheng Z; Sun Y; Han Y; Dong J; Lu M
    Horm Metab Res; 2021 Sep; 53(9):625-632. PubMed ID: 34496413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
    Ding C; Shi T; Wu G; Man J; Han H; Cui Y
    Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.